5-HT2/dopamine D3 antagonists (Sigma-Tau)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Name5-HT2/dopamine D3 antagonists (Sigma-Tau)
Drug Alias Name(+)-ST-1460St 1615ST 1455ST 1469ST 1460 +[7] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin 2 (5-HT2) receptor antagonistsDopamine D3 receptor antagonists
TargetsSerotonin 2 (5-HT2) receptorDopamine D3 receptor
Therapy Area/IndicationsSchizophreniaPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSigma-Tau Industrie Farmaceutiche Riunite Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSigma-Tau Industrie Farmaceutiche Riunite Spa
Active IndicationsN/A
Inactive IndicationsSchizophreniaPsychotic Disorders

Other Information

ATC CodeN/A
Related LinksN/A